Core Insights - The logistics sector experienced a rise of 1.44% on November 10, with *ST Yuanshang leading the gains [1] - The Shanghai Composite Index closed at 4018.6, up 0.53%, while the Shenzhen Component Index closed at 13427.61, up 0.18% [1] Stock Performance - *ST Yuanshang (603813) closed at 34.35, up 5.01% with a trading volume of 15,300 [1] - Guanghui Logistics (600603) closed at 7.80, up 3.59% with a trading volume of 288,600 [1] - Xiamen Xiangyu (600057) closed at 8.70, up 3.33% with a trading volume of 361,800 [1] - Jianshe Co. (600153) closed at 10.56, up 3.12% with a trading volume of 357,800 [1] - Milkewei (603713) closed at 61.84, up 3.00% with a trading volume of 29,200 [1] - Shentong Express (002468) closed at 15.54, up 2.57% with a trading volume of 247,800 [1] - Chuanhua Zhili (002010) closed at 6.29, up 2.44% with a trading volume of 415,600 [1] - YTO Express (600233) closed at 16.85, up 2.12% with a trading volume of 149,200 [1] - *ST Haiqin (600753) closed at 7.78, up 2.10% with a trading volume of 29,500 [1] - SF Holding (002352) closed at 40.80, up 2.05% with a trading volume of 362,500 [1] Capital Flow - The logistics sector saw a net inflow of 84.64 million yuan from main funds, while retail funds experienced a net outflow of 100 million yuan [2] - Retail investors contributed a net inflow of 15.74 million yuan [2] Individual Stock Capital Flow - SF Holding (002352) had a main fund net inflow of 1.15 million yuan, with retail net inflow of 15.41 million yuan [3] - Chuanhua Zhili (002010) saw a main fund net inflow of 28.29 million yuan, but retail funds had a net outflow of 13.33 million yuan [3] - Shanghai Yashi (603329) experienced a main fund net inflow of 20.30 million yuan, with a retail net outflow of 14.06 million yuan [3] - Guanghui Logistics (600603) had a main fund net inflow of 9.01 million yuan, with retail net outflow of 7.86 million yuan [3]

Core Viewpoint - Dongfang Jiasheng (002889) announced that neither the company nor its controlling subsidiaries have overdue guarantee matters or guarantee litigation, and there are no guarantees provided for major shareholders, actual controllers, or their related parties [1] Summary by Categories - **Company Status** - Dongfang Jiasheng confirmed the absence of overdue guarantee matters and guarantee litigation [1] - The company does not provide guarantees for major shareholders or actual controllers [1]

证券代码：002889 证券简称：东方嘉盛 公告编号：2025-038 深圳市东方嘉盛供应链股份有限公司 关于为子公司新增银行贷款提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、担保情况概述 二、担保进展情况 近日，公司与中国工商银行深圳分行（以下简称"工商银行"）签署了《最 高额保证合同》，为华盛嘉阳智慧供应链提供其与工商银行签订的主合同《固定 资产借款合同》项下在人民币34,000.00万元（大写：叁亿肆仟万元整）的最高 余额内主债权的连带责任保证担保。 三、担保协议主要内容 1、合同主体 债权人：中国工商银行股份有限公司深圳东门支行 保证人：深圳市东方嘉盛供应链股份有限公司 2、担保的最高债权金额：34,000 万元 3、保证方式：连带责任保证 深圳市东方嘉盛供应链股份有限公司（以下简称"公司"）分别于2025年9 月28日、2025年10月15日召开的第六届董事会第六次会议、2025年第二次临时股 东大会，审议并通过了《关于为子公司新增银行贷款提供担保的议案》。同意子 公司深圳市华盛嘉阳智慧供应链有限公司（以下简称"华盛嘉阳智慧 ...

Financial Performance - The company reported a total revenue of 2.902 billion yuan for Q3 2025, an increase of 12.63% year-on-year, while the net profit attributable to shareholders was 141 million yuan, a decrease of 21.2% [1] - In Q3 2025, the total revenue was 790 million yuan, a decline of 22.1% year-on-year, but the net profit attributable to shareholders increased by 22.95% to 61.585 million yuan [1] - The gross margin decreased to 9.75%, down 22.37% year-on-year, and the net margin fell to 5.03%, down 30.71% year-on-year [1] Accounts Receivable and Debt - Accounts receivable increased significantly, with a year-on-year growth of 113.79%, reaching 1.531 billion yuan [1] - Interest-bearing liabilities rose to 1.786 billion yuan, an increase of 24.27% year-on-year [1] - The company's cash assets are considered healthy, but the debt ratio has reached 34.33% [3] Semiconductor Business - The company is expanding its semiconductor customer base and has established new partnerships with domestic and international semiconductor firms [4] - The company aims to enhance service cooperation with key clients in the semiconductor industry and improve supply chain management products [4] International Logistics - The international logistics segment saw a revenue increase of 329.56% year-on-year in the first half of 2025 [4] - The company is developing a flexible supply chain solution by integrating various transportation modes, enhancing its international logistics capabilities [4] Digital Transformation - The company is investing in big data and AI technologies to optimize international logistics processes and improve service quality [5] - Plans include the development of smart logistics networks and automated warehouses to enhance operational efficiency [5] Self-built Warehousing Projects - The company is making progress with self-built warehousing projects in Chongqing and Kunming, which are expected to contribute positively to performance [6] - Ongoing projects in Shenzhen are also aimed at serving the cross-border e-commerce and semiconductor sectors [6]

Core Viewpoint - The company, Shenzhen Oriental Jiasheng Supply Chain Co., Ltd., has released its third-quarter report for 2025, ensuring that the information disclosed is true, accurate, and complete, with no false records or misleading statements [1][2][7]. Financial Data - The third-quarter financial report has not been audited [3][6]. - The company has made retrospective adjustments to previous accounting data due to a capital reserve conversion completed in May 2025, affecting the earnings per share from the previous year [3][4]. Corporate Governance - The board of directors and the supervisory board have confirmed the authenticity and completeness of the quarterly report, taking legal responsibility for any inaccuracies [2][9]. - The sixth board of directors' seventh meeting was held on October 24, 2025, with all seven directors present, and the meeting complied with legal and regulatory requirements [6][7]. Shareholder Information - The report includes details on the total number of ordinary shareholders and the shareholding status of the top ten shareholders, although specific figures are not provided in the documents [4][5].

Core Viewpoint - Dongfang Jiasheng (002889.SZ) reported a decline in operating revenue for Q3 2025, while net profit attributable to shareholders increased, indicating mixed financial performance [1] Financial Performance - Operating revenue for Q3 2025 was 789 million yuan, a year-on-year decrease of 22.17% [1] - Net profit attributable to shareholders was 61.5851 million yuan, reflecting a year-on-year increase of 22.95% [1] - Net profit attributable to shareholders after deducting non-recurring gains and losses was 26.4132 million yuan, showing a year-on-year decline of 29.33% [1]

Group 1 - The core point of the article is that Dongfang Jiasheng (SZ 002889) held its seventh board meeting on October 24, 2025, to review the proposal for the third quarter report of 2025 [1] - For the first half of 2025, Dongfang Jiasheng's revenue composition shows that supply chain management services accounted for 99.88%, while other businesses made up 0.12% [1] - As of the report date, Dongfang Jiasheng has a market capitalization of 5.7 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - There is a discussion on the hot secondary market for biomedicine, while the primary market is facing challenges in fundraising [1]

Group 1 - The core viewpoint of the article highlights the financial performance of Dongfang Jiasheng in Q3 2025, showing a revenue increase but a decline in net profit and earnings per share [1] - Dongfang Jiasheng reported a revenue of approximately 2.898 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 12.63% [1] - The net profit attributable to shareholders was approximately 141 million yuan, reflecting a year-on-year decrease of 21.2% [1] - The basic earnings per share were reported at 0.3757 yuan, which is a decrease of 21.24% compared to the previous year [1] Group 2 - As of the report, Dongfang Jiasheng has a market capitalization of 5.7 billion yuan [2] - The article discusses the broader context of the biopharmaceutical market, noting that China’s innovative drugs have generated 80 billion USD in overseas licensing this year [2] - The conversation with Lu Gang, a partner at Chuangdong Investment, indicates a contrast between the hot secondary market for biopharmaceuticals and the cooling fundraising environment in the primary market [2]

证券代码：002889 证券简称：东方嘉盛 公告编号：2025-036 深圳市东方嘉盛供应链股份有限公司 二、监事会会议审议情况 （一）、审议通过《关于公司〈2025 年第三季度报告〉的议案》 经审核，监事会认为董事会编制和审核深圳市东方嘉盛供应链股份有限公司 2025 年第三季度报告的程序符合法律、行政法规和中国证监会的规定，报告内 容真实、准确、完整地反映了上市公司的实际情况，不存在任何虚假记载、误导 性陈述或者重大遗漏。 表决结果：3 票同意，0 票反对，0 票弃权。 第六届监事会第七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 深圳市东方嘉盛供应链股份有限公司（以下简称"公司"）第六届监事会第 七次会议于 2025 年 10 月 24 日（星期五）在深圳市福田区保税区市花路 10 号东 方嘉盛大厦 6 楼以现场结合通讯的方式召开。会议通知已于 2025 年 10 月 21 日 通过邮件及短信的方式送达各位监事。本次会议应出席监事 3 人，实际出席监事 3 人。 会议由监事会主席何一鸣主持，公司部分高级管理人员列 ...

（一）审议通过《关于公司〈2025 年第三季度报告〉的议案》 经审议，董事会认为：公司《2025 年第三季度报告》符合法律、行政法规 要求，报告内容真实、准确、完整地反映了公司 2025 年前三季度的经营情况， 不存在虚假记载、误导性陈述或者重大遗漏。 具体内容详见公司披露于巨潮资讯网（http://www.cninfo.com.cn）的《2025 年第三季度报告》（公告编号：2025-037）。 证券代码：002889 证券简称：东方嘉盛 公告编号：2025-035 深圳市东方嘉盛供应链股份有限公司 第六届董事会第七次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 一、董事会会议召开情况 深圳市东方嘉盛供应链股份有限公司（以下简称"公司"）第六届董事会第 七次会议于 2025 年 10 月 24 日（星期五）在深圳市福田区保税区市花路 10 号东 方嘉盛大厦 6 楼以现场结合通讯的方式召开。会议通知已于 2025 年 10 月 21 日 通过邮件及短信的方式送达各位董事。本次会议应出席董事 7 人，实际出席董事 7 人。 会议由董事孙卫平主持， ...